New technique shields healthy liver during cancer radiation
NCT ID NCT06229080
Summary
This study tested a technique to protect healthy liver tissue during a radiation treatment called Y90 radioembolization for liver cancer. Researchers used temporary, dissolving particles to block blood flow to healthy areas, aiming to direct more radiation to the tumor while sparing normal liver function. The trial involved 20 adults with liver cancer to see if this approach was safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER (PRIMARY AND METASTATIC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.